Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Case Study Highlights INDIBA 448 kHz Radiofrequency's Role in Visceral Fat Reduction and Prevention of Fat Accumulation ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...

Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like ...